We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

142 hedge funds and large institutions have $727M invested in Aerie Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

10% less funds holding

Funds holding: 158 → 142 (-16)

12% less capital invested

Capital invested by funds: $830M → $727M (-$104M)

17% less call options, than puts

Call options by funds: $281K | Put options by funds: $337K

52% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 31

Holders
142
Holders Change
-16
Holders Change %
-10.13%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
59
Reduced
45
Closed
31
Calls
$281K
Puts
$337K
Net Calls
-$56K
Net Calls Change
+$1.2M

Top Buyers

Rank Fund Capital Flow
1
William Blair Investment Management
William Blair Investment Management
Illinois
+$9.41M
2
LCS
Levin Capital Strategies
New York
+$7.48M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$6.48M
4
DM
Deerfield Management
New York
+$5.69M
5
MGIM
M&G Investment Management
United Kingdom
+$4.89M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$29.8M
2
RCMNY
Rubric Capital Management (New York)
New York
-$8.59M
3
CS
Candriam SCA
Luxembourg
-$7.48M
4
NHAS
Novo Holdings A/S
Denmark
-$4M
5
BlackRock
BlackRock
New York
-$3.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
SSB
126
Sandy Spring Bank
Maryland
$19K +$20.4K +1,189 New
PCM
127
Penserra Capital Management
California
$17K – – –
LJHT
128
Laurie J. Hall Trustee
$11K – – –
Simplex Trading
129
Simplex Trading
Illinois
$10K -$3.88K -226 -26%
Rockefeller Capital Management
130
Rockefeller Capital Management
New York
$10K +$11.2K +655 New
LC
131
Lindbrook Capital
California
$8K – – –
CAPTRUST Financial Advisors
132
CAPTRUST Financial Advisors
North Carolina
$6K +$6.45K +376 New
MGIM
133
M&G Investment Management
United Kingdom
$4.56K +$4.89M +285,115 New
HI
134
Harbour Investments
Wisconsin
$3K -$51 -3 -2%
Carson Wealth (CWM LLC)
135
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
Daiwa Securities Group
136
Daiwa Securities Group
Japan
$2K – – –
PNC Financial Services Group
137
PNC Financial Services Group
Pennsylvania
$2K – – –
S
138
SignatureFD
Georgia
$2K +$2.66K +155 New
ASN
139
Advisory Services Network
Georgia
$1K +$875 +51 New
PAM
140
Panagora Asset Management
Massachusetts
$1K +$1.18K +69 New
AIG
141
American International Group
New York
$380 +$40.1K +2,340 +11%
Nisa Investment Advisors
142
Nisa Investment Advisors
Missouri
$11 – – –
CS
143
Candriam SCA
Luxembourg
– -$7.48M -576,495 Closed
RCMNY
144
Rubric Capital Management (New York)
New York
– -$8.59M -480,402 Closed
CM
145
Caption Management
Oklahoma
– -$1.68M -93,808 Closed
California Public Employees Retirement System
146
California Public Employees Retirement System
California
– -$1.35M -75,400 Closed
CSS
147
Cubist Systematic Strategies
Connecticut
– -$1.29M -72,413 Closed
TLP
148
Tri Locum Partners
New York
– -$1.22M -68,472 Closed
Dimensional Fund Advisors
149
Dimensional Fund Advisors
Texas
– -$1.02M -57,095 Closed
KOCAA
150
Knights of Columbus Asset Advisors
Connecticut
– -$732K -40,956 Closed
3 4 5
6
7

AERI Hedge Fund Activity: Q2 2021 in Review

142 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q2 2021, worth a combined $727M — down 12% from $830M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of AERI and 15 opened new positions — a net loss of 16 holders — while 45 trimmed existing stakes and 59 added.

The largest buyer was William Blair Investment Management, adding an estimated $9.41M. The largest seller was Woodline Partners, cutting an estimated $29.8M.

  • 142 institutional investors held Aerie Pharmaceuticals (AERI) as of Q2 2021, down from 158 in Q1 2021.
  • Funds reported $727M of Aerie Pharmaceuticals stock for Q2 2021, down 12% quarter-over-quarter.
  • 15 funds opened new Aerie Pharmaceuticals positions in Q2 2021 and 31 closed out, a net change of -16 holders.
  • The largest Aerie Pharmaceuticals buyer in Q2 2021 was William Blair Investment Management, an estimated $9.41M added.
  • The largest Aerie Pharmaceuticals seller in Q2 2021 was Woodline Partners, an estimated $29.8M sold.

Based on aggregated 13F filings for Q2 2021.